How to check the Mankind Pharma Limited IPO allotment status?
When the allotment process is completed, you can check the status of your application on the Upstox app. Share allotment is generally done around five to six days after an IPO closes.
Here’s a step-by-step guide on how to check the Mankind Pharma Ltd IPO allotment status:
About Mankind Pharma Limited IPO
Incorporated in 1991, Mankind Pharma develops, manufactures, and markets a wide range of pharmaceutical and consumer healthcare products. Its products are used to treat various acute and chronic diseases.
Over the years, the company has established “Mankind” as a well-recognized brand in India. In FY22, it was the fourth-largest pharmaceutical company in domestic sales and second largest in terms of sales volume. Meanwhile, its consumer healthcare business, which started in 2007, has established several brands like Manforce, Prega News, Unwanted-72.
As on 31 March 2022, the company has 23 manufacturing facilities across India with a total installed capacity of 40.7 billion units. Its facilities have obtained various approvals from regulatory bodies, including USFDA, WHO and CDSCO. Along with manufacturing, the company has a pan-India distribution network with a field force of over 11,000 medical representatives.
Mankind Pharma is coming out with its initial public offer (IPO). The IPO will be a complete offer for sales where existing shareholders and promoters sell over four crore shares. Meanwhile, the company shares will be listed on NSE and BSE.
Here are key details about the Mankind Pharma IPO:
Here’s a quick look at Mankind Pharma Limited IPO’s strengths, weakness, opportunities and risks (SWOT analysis)
Strengths and opportunities
Risks and threats
Mankind Pharma Limited IPO details
| Mankind Pharma Limited IPO date
The company has filed its Draft Red Herring Prospectus with the market regulator SEBI. The offer document filed by the company with the SEBI mentions that the Mankind Pharma IPO’s opening date – in other words, the Mankind Pharma IPO launch date – will be 25th April 2023. The Mankind Pharma IPO closing date is 27th April 2023. After this, investors will be updated about the allotment status on 3rd May 2023.
Investors, who have been allotted shares, can expect them to be credited to their demat account on 8 May 2023. The Mankind Pharma IPO listing date is 9 May 2023. The listing date is the date on which the shares of a company get listed on the bourses – NSE and BSE.
| Mankind Pharma Limited IPO Price Band
The entire IPO is a book-built issue. The Mankind Pharma IPO price band has been set between ₹1,026 and ₹1,080 per share. Interested investors can choose a price within this band to apply for the IPO.
The Mankind Pharma IPO listing price will be determined on 9th May 2023. The listing price is the price at which a company’s shares debut on the stock exchanges.
| Mankind Pharma Limited IPO Lot size
The Mankind Pharma IPO details have been declared. The Mankind Pharma IPO lot size is set at 13 shares and an investor can apply for a minimum of 1 lot. Meanwhile, the Mankind Pharma IPO issue size is approx ₹4,326 crore.
How to apply for the Mankind Pharma Limited IPO?
If you are interested in this investment opportunity but unsure how to apply for the Mankind Pharma IPO, here are the steps that you need to follow.
When the public issue opens for subscription, one can follow this step-by-step guide on how to apply for the Mankind Pharma Ltd IPO on Upstox:
Open a demat account with Upstox to apply for the Mankind Pharma Limited IPO
To apply for the Mankind Pharma Ltd IPO, you need to mandatorily have a demat account. A demat account helps you hold the shares you buy in a dematerialised format. If you don’t have a demat account yet, you can open one with Upstox by visiting our website or by downloading the app.
Here is a step-by-step guide on how to open a demat account with Upstox:
This is all it takes to open a demat account with Upstox. Easy and quick, right?
Upstox – trading app to apply for the Mankind Pharma Limited IPO
Applying for IPOs with Upstox is extremely easy. The user-friendly interface and top-notch security make Upstox one of the leading trading apps in India.
You can apply for the Mankind Pharma IPO on Upstox, provided you have a demat account. As mentioned in the previous section, you can simply follow the steps to open a demat account with Upstox. The biggest advantage is that when you apply for an IPO using your Upstox account, the brokerage charges are zero.
In fact, due to its robust features and minimal charges, Upstox is among the most preferred trading apps. Lakhs of Indians trust Upstox as it is a reliable trading platform that makes IPO applications easy.
Pre-applying for the Mankind Pharma IPO means applying for this public issue before it goes live. Click here to pre-apply for the Mankind Pharma IPO on Upstox.
You can pre-apply for the Mankind Pharma IPO from 21st April 2023. Once the IPO goes live, you will receive a UPI mandate. Accept this to block the IPO application amount and successfully place your bid.
You can apply on Upstox’s website and app, once the Mankind Pharma IPO opens for the subscription.
The Mankind Pharma IPO launch date is 25th April 2023. The Mankind Pharma IPO will be open for subscription till 27th April 2023.
The Mankind Pharma lot size is 13 shares and the minimum investment required is ₹13,338.
The Mankind Pharma IPO price band is ₹1,026 – ₹1,080 per share.
The size of the Mankind Pharma IPO is approx. ₹4,326 crore.
You can place up to three bids for an application.
No, the bids have to be placed in one go. If you want to add an additional bid, then you would have to delete your application and re-apply.
If shares are allotted, then they will be credited to your demat account on 8th May 2023.
Mankind Pharma shares will be on NSE and BSE.
Mankind Pharma shares’ listing date is 9th May 2023.